Canadian Sec - Delayed Quote CAD

Pharmadrug Inc. (PHRX.CN)

0.0300 -0.0050 (-14.29%)
At close: April 26 at 3:43 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
7.0090
683.6710
Cost of Revenue
0.0080
2.2630
9.1640
501.6340
Gross Profit
-0.0080
-2.2630
-2.1550
182.0370
Operating Expense
1,035.0310
2,418.4610
2,794.3400
4,020.7520
Operating Income
-1,035.0390
-2,420.7240
-2,796.4950
-3,838.7150
Net Non Operating Interest Income Expense
-303.7580
-223.3140
-60.1290
-321.2930
Other Income Expense
2,601.4180
-610.0490
-1,427.3500
-1,742.6190
Pretax Income
1,262.6200
-3,254.0870
-4,283.9740
-5,902.6270
Tax Provision
--
-190.0000
--
-475.0120
Net Income Common Stockholders
-1,480.9330
-8,875.6870
-5,873.5540
-5,150.2810
Diluted NI Available to Com Stockholders
-1,480.9330
-8,875.6870
-5,873.5540
-5,150.2810
Basic EPS
-0.03
-0.18
-0.01
-0.27
Diluted EPS
-0.03
-0.18
-0.01
-0.27
Basic Average Shares
50,805.5000
50,094.5340
47,311.6160
20,350.9190
Diluted Average Shares
50,805.5000
50,094.5340
47,311.6160
20,350.9190
Total Expenses
1,035.0390
2,420.7240
2,803.5040
4,522.3860
Net Income from Continuing & Discontinued Operation
-1,480.9330
-8,875.6870
-5,873.5540
-5,150.2810
Normalized Income
-101.1490
-2,498.3317
-2,839.5840
-3,555.8140
Interest Income
--
--
--
32.2440
Interest Expense
303.7850
223.3140
60.1290
353.5370
Net Interest Income
-303.7580
-223.3140
-60.1290
-321.2930
EBIT
1,566.4050
-3,030.7730
-4,223.8450
-5,549.0900
EBITDA
1,566.4050
-3,009.7450
-4,207.8270
-4,252.5160
Reconciled Cost of Revenue
8.5290
2.2630
9.1640
501.6340
Reconciled Depreciation
-8.5210
21.0280
16.0180
1,296.5740
Net Income from Continuing Operation Net Minority Interest
1,452.6200
-3,064.0870
-4,283.9740
-5,150.2810
Total Unusual Items Excluding Goodwill
2,589.6150
-600.8370
-1,444.3900
-1,734.0110
Total Unusual Items
2,589.6150
-600.8370
-1,444.3900
-1,734.0110
Normalized EBITDA
-1,023.2100
-2,408.9080
-2,763.4370
-2,518.5050
Tax Rate for Calcs
0.0004
0.0001
--
0.0001
Tax Effect of Unusual Items
1,035.8460
-35.0817
--
-139.5440
12/31/2020 - 1/31/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TRIP.CN Red Light Holland Corp.
0.0550
0.00%
 
SILO.CN Silo Wellness Inc.
0.0100
0.00%
 
MYCO.CN Mydecine Innovations Group Inc.
0.0150
-25.00%
 
LOVE.V Cannara Biotech Inc.
0.8400
-1.18%
 
DN.TO Delta 9 Cannabis Inc.
0.0250
+25.00%
 
RVV.CN Revive Therapeutics Ltd.
0.0300
+20.00%
 
OMND.CN Optimind Pharma Corp.
0.0050
0.00%
 
SILFF Silo Wellness Inc.
0.0112
0.00%
 
WIB.CN West Island Brands Inc.
0.1300
0.00%
 
OPTI.CN Optimi Health Corp.
0.3400
-2.86%